Trial of Acupuncture Added to Usual Treatment for Fibromyalgia
A Randomized Controlled Trial of Acupuncture Added to Usual Treatment for Fibromyalgia
1 other identifier
interventional
58
1 country
1
Brief Summary
The aim of this study was to evaluate the effect of acupuncture as a treatment for this condition. Fifty-eight women diagnosed with fibromyalgia were randomly allocated to two groups. One group received acupuncture (n=34) twice a week for 20 sessions in addition to tricyclic antidepressants and exercises. The control group (n=24) received only tricyclic antidepressants and exercises. A blinded assessor evaluated patients' pain using visual analog scale (VAS), tender points number (TePsN) and myalgic index (MI). The same assessor also evaluated quality of life (QoL) using SF-36. These evaluations were done prior to treatments, at the end of the 20 sessions, and again at six months, one year and two years after the first evaluation. At the end of the 20 sessions, patients who had received acupuncture were significantly better than those who had not in all measures of pain (VAS, TePsN, MI) and in five subscales of SF-36. After six months, the acupuncture group was significantly better than the control group in some measures of pain (TePsN and MI) and in three subscales of SF-36. After one year, the acupuncture group showed significant advantage in only one subscale of SF-36; at two years there were no significant differences between the two groups on all outcome measures. The addition of acupuncture to usual treatment for fibromyalgia is beneficial for pain and quality of life, but only in first six months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for early_phase_1
Started Apr 2000
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2000
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2002
CompletedFirst Submitted
Initial submission to the registry
September 21, 2006
CompletedFirst Posted
Study publicly available on registry
September 22, 2006
CompletedSeptember 22, 2006
September 1, 2006
September 21, 2006
September 21, 2006
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
VAS(Visual Analogical Scale)
SF-36(Short Form 36)
Myalgic Index
Number of tender points
Secondary Outcomes (4)
VAS(Visual Analogical Scale)(5 times)
SF-36(Short Form 36)(5 times)
Myalgic Index(5 times)
Number of tender points(5 times)
Interventions
Eligibility Criteria
You may qualify if:
- Patients had to report moderate to severe pain intensity (VAS \> four), and they had to be using antidepressant medication in an analgesic dose (between 12.5mg/day and 75mg/day).
You may not qualify if:
- Patients were excluded in the case of severe psychiatric disease, the presence of neurological deficits, cardiac disease or glaucoma, and treatment with acupuncture within one year prior to the start of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo
São Paulo, São Paulo, 05403010, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rosa A Targino, MD
University of Sao Paulo-School of Medicine
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 21, 2006
First Posted
September 22, 2006
Study Start
April 1, 2000
Study Completion
May 1, 2002
Last Updated
September 22, 2006
Record last verified: 2006-09